203 related articles for article (PubMed ID: 27345657)
61. [Oncogenes and cancer of the larynx. EGFR, p21 ras and HPV-DNA infections].
Almadori G; Cadoni G; Maurizi M; Ottaviani F; Paludetti G; Cattani P; Scambia G
Acta Otorhinolaryngol Ital; 1995 Feb; 15(1 Suppl 46):1-22. PubMed ID: 7793243
[TBL] [Abstract][Full Text] [Related]
62. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.
Berns EM; Foekens JA; Vossen R; Look MP; Devilee P; Henzen-Logmans SC; van Staveren IL; van Putten WL; Inganäs M; Meijer-van Gelder ME; Cornelisse C; Claassen CJ; Portengen H; Bakker B; Klijn JG
Cancer Res; 2000 Apr; 60(8):2155-62. PubMed ID: 10786679
[TBL] [Abstract][Full Text] [Related]
63. The role of human papillomavirus in laryngeal cancer in Southern China.
Lam EWH; Chan MMH; Wai CKC; Ngai CM; Chen Z; Wong MCS; Yeung ACM; Tong JHM; Chan ABW; To KF; Chan PKS
J Med Virol; 2018 Jun; 90(6):1150-1159. PubMed ID: 29446476
[TBL] [Abstract][Full Text] [Related]
64. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas.
Ikenberg H; Matthay K; Schmitt B; Bauknecht T; Kiechle-Schwarz M; Göppinger A; Pfleiderer A
Cancer; 1995 Jul; 76(1):57-66. PubMed ID: 8630877
[TBL] [Abstract][Full Text] [Related]
65. Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: biologic function and clinical significance.
Almadori G; Galli J; Cadoni G; Bussu F; Maurizi M
Head Neck; 2002 Jun; 24(6):597-604. PubMed ID: 12112558
[TBL] [Abstract][Full Text] [Related]
66. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ
Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303
[TBL] [Abstract][Full Text] [Related]
67. Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas.
Loeb KR; Asgari MM; Hawes SE; Feng Q; Stern JE; Jiang M; Argenyi ZB; de Villiers EM; Kiviat NB
PLoS One; 2012; 7(4):e34422. PubMed ID: 22545084
[TBL] [Abstract][Full Text] [Related]
68. Localization of p53 protein and human papillomavirus in laryngeal squamous lesions.
Caruso ML; Valentini AM
Anticancer Res; 1997; 17(6D):4671-5. PubMed ID: 9494587
[TBL] [Abstract][Full Text] [Related]
69. Absence of disruptive TP53 mutations in high-risk human papillomavirus-driven neck squamous cell carcinoma of unknown primary.
Boscolo-Rizzo P; Schroeder L; Sacchetto V; Holzinger D; Da Mosto MC; Tirelli G; Dal Cin E; Mantovani M; Menegaldo A; Del Mistro A; Romeo S; Dei Tos AP; Niero M; Rigo S; Dyckhoff G; Hess J; Alemany L; Quer M; León X; Polesel J; Pawlita M; Bertorelle R
Head Neck; 2019 Nov; 41(11):3833-3841. PubMed ID: 31414564
[TBL] [Abstract][Full Text] [Related]
70. High incidence of high-risk HPV in benign and malignant lesions of the larynx.
Duray A; Descamps G; Arafa M; Decaestecker C; Remmelink M; Sirtaine N; Ernoux-Neufcoeur P; Mutijima E; Somja J; Depuydt CE; Delvenne P; Saussez S
Int J Oncol; 2011 Jul; 39(1):51-9. PubMed ID: 21573490
[TBL] [Abstract][Full Text] [Related]
71. Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer: an analysis of the TAX 324 trial.
Wu Y; Posner MR; Schumaker LM; Nikitakis N; Goloubeva O; Tan M; Lu C; Iqbal S; Lorch J; Sarlis NJ; Haddad RI; Cullen KJ
Cancer; 2012 Apr; 118(7):1811-7. PubMed ID: 22009819
[TBL] [Abstract][Full Text] [Related]
72. Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group.
Bradford CR; Zhu S; Wolf GT; Poore J; Fisher SG; Beals T; McClatchey KD; Carey TE
Otolaryngol Head Neck Surg; 1995 Oct; 113(4):408-12. PubMed ID: 7567013
[TBL] [Abstract][Full Text] [Related]
73. TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas.
Gillet E; Alentorn A; Doukouré B; Mundwiller E; van Thuijl HF; Reijneveld JC; Medina JA; Liou A; Marie Y; Mokhtari K; Hoang-Xuan K; Sanson M; Delattre JY; Idbaih A
J Neurooncol; 2014 May; 118(1):131-9. PubMed ID: 24590827
[TBL] [Abstract][Full Text] [Related]
74. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
[TBL] [Abstract][Full Text] [Related]
75. Mutation patterns in recurrent and/or metastatic oropharyngeal squamous cell carcinomas in relation to human papillomavirus status.
Reder H; Wagner S; Wuerdemann N; Langer C; Sandmann S; Braeuninger A; Dugas M; Gattenloehner S; Wittekindt C; Klussmann JP
Cancer Med; 2021 Feb; 10(4):1347-1356. PubMed ID: 33527763
[TBL] [Abstract][Full Text] [Related]
76. Mutational Status of CDKN2A and TP53 Genes in Laryngeal Squamous Cell Carcinoma.
Todorova TA; Jordanov SH; Stancheva GS; Chalakov IJ; Melnicharov MB; Kunev KV; Mitev VI; Kaneva RP; Goranova TE
Pathol Oncol Res; 2015 Apr; 21(2):413-21. PubMed ID: 25149524
[TBL] [Abstract][Full Text] [Related]
77. Prevalence and Prognostic Significance of HPV in Laryngeal Squamous Cell Carcinoma in Northeast China.
Tong F; Geng J; Yan B; Lou H; Chen X; Duan C; He J; Zhang S; Xie H; Li H; Yuan D; Zhang F; Meng H; Wei L
Cell Physiol Biochem; 2018; 49(1):206-216. PubMed ID: 30134232
[TBL] [Abstract][Full Text] [Related]
78. Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.
Berns EM; van Staveren IL; Look MP; Smid M; Klijn JG; Foekens JA
Br J Cancer; 1998 Apr; 77(7):1130-6. PubMed ID: 9569050
[TBL] [Abstract][Full Text] [Related]
79. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
[TBL] [Abstract][Full Text] [Related]
80. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
